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A previously healthy 60-year-old woman presented with
a 3-week history of fatigue and exertional dyspnea. Over the
past year, she had experienced episodic wheezing, facial
flushing, diarrhoea, and an unintentional 40-lb weight loss.
On physical examination, she demonstrated venous telangi-
ectasia in the malar region, mild peripheral cyanosis, and an
elevated jugular venous pressure with a dominant V wave.
On cardiac auscultation, there was a holosystolic murmur at
the left lower sternal region of grade III/VI intensity that
increased on inspiration. Transthoracic echocardiography
was performed to confirm the valvular abnormalities detec-
ted on physical examination (Figure 1A). Cardiac magnetic
resonance imaging (CMR) was performed to quantify right
ventricular systolic function and computed tomography of
the abdomen was performed as shown Figures 1B and C.
Diagnosis
Carcinoid syndrome.
Radiologic Findings
Transthoracic echocardiography identified severe tricuspid
valve regurgitation with thickened immobile leaflets
(Figure 1A). CMR imaging confirmed the echocardiographicKey Words: Carcinoid syndrome; Tricuspid regurgitation;
Echocardiography; Cardiac magnetic resonance imaging.
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index (98 mL/m2) and mild right ventricular systolic
dysfunction with an ejection fraction (EF) of 45% (Figure 1B).
Computed tomography of the abdomen revealed multiple
hypodensities in the liver and a mesenteric mass, with evidence
of a primary small-bowel tumour (Figure 1C).Discussion
Carcinoid tumours are relatively rare, with an incidence of
3e4 per 100,000 population per year [1]. The primary
tumour is located in the gastrointestinal tract or the bron-
chopulmonary tree in more than 98% of cases [2]. Cardiac
involvement is the presenting feature in fewer than 20% of
cases but develops in more than 50% of cases [3]. The right-
sided valves, with the tricuspid valve in all patients and the
pulmonary valve in the majority of patients, are the major
sites of cardiac involvement [3]. Left-sided heart disease is
significantly less common and is usually associated with
a patent foramen ovale [3]. Valvular lesions are characterized
by shortened, thickened, and immobile leaflets. This leads to
valvular regurgitation and can result in combined regurgita-
tion and stenosis of the affected valve [3]. Right ventricular
volume overload and dilatation may occur as a result of the
tricuspid regurgitation. CMR offers additional information in
terms of detailed evaluation of accurate right ventricular
volumes and systolic function [3]. Our case supports the use
of multimodality cardiac imaging for the diagnosis and
anatomic characterization of carcinoid heart disease.
In our patient, markedly elevated levels of 5-hydrox-
yindolacetic acid, and chromogranin A confirmed the diag-
nosis of carcinoid syndrome. In the absence of surgical
intervention, individuals with carcinoid heart disease may
develop worsening symptomatic right-sided heart failure.ll rights reserved.
Figure 1. (A) Transthoracic echocardiographic right ventricular inflow view, demonstrating immobile tricuspid valve leaflets (arrows) consistent with carcinoid
heart disease. (B) Four-chamber view obtained with balanced, steady-state, free precession magnetic resonance, demonstrating a linear signal void that resulted
from tricuspid regurgitation (arrow) because of carcinoid heart disease. (C) Coronal contrast-enhanced computed tomography image, demonstrating a spec-
ulated nodal mass in the mesentery (arrow), which has metastasized from a more inferiorly located primary tumour in the small bowel (arrowhead).
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disease and with cardiac involvement is 1.6 years compared
with 4.6 years for those without cardiac involvement [4]. Our
patient underwent tricuspid valve replacement and closure of
the patent foramen ovale. Before surgery, a continuous
infusion of octreotide was started to prevent perioperative
complications of carcinoid syndrome. After surgery, the
patient initiated monthly octreotide injections and interferon
alpha therapy, with significant improvement in her symptoms
at 1 year of follow-up.References
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